Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and Jun 2026.
- Largest single sale: $545K (2,145 shares) of Ligand Pharmaceuticals Inc on Jun 16, 2026. Filing
- Last sale before this period: Mar 5, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ligand Pharmaceuticals Inc (LGND) | Director | Aug 7, 2008 | Jun 18, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 16, 2026, Ligand Pharmaceuticals Inc: sold 2,145 shares for $545K, no plan disclosed; 2,145 shares acquired by exercising options. 1 filing: 1
- Jun 5, 2026, Ligand Pharmaceuticals Inc: 836 shares granted. 1 filing: 1
- Mar 23, 2026, Ligand Pharmaceuticals Inc: sold 1,000 shares for $208K, no plan disclosed. 1 filing: 1
- Mar 3, 2026, Ligand Pharmaceuticals Inc: sold 2,034 shares for $410K, no plan disclosed; 2,034 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.